U.S., Aug. 20 -- ClinicalTrials.gov registry received information related to the study (NCT07129837) titled 'Serum Anti-PCOLCE as Novel Diagnostic Biomarker in Rheumatoid Arthritis With Emphasis on Se... Read More
U.S., Aug. 20 -- ClinicalTrials.gov registry received information related to the study (NCT07128836) titled 'Effects of Insole Vibration With Proprioceptive Training in Patients With Diabetic Peripher... Read More
U.S., Aug. 20 -- ClinicalTrials.gov registry received information related to the study (NCT07130799) titled 'Innate Immune Response Monitoring Via Monocyte HLA-DR in Severe Intra-abdominal Infections ... Read More
U.S., Aug. 20 -- ClinicalTrials.gov registry received information related to the study (NCT07130370) titled 'Mindfulness-informed Intervention for Improving Diabetes Outcomes in Type 2 Diabetes' on Au... Read More
U.S., Aug. 20 -- ClinicalTrials.gov registry received information related to the study (NCT07129915) titled 'Communication and Shared Decision Making for Diabetes Self-Management' on Aug. 01. Brief S... Read More
U.S., Aug. 20 -- ClinicalTrials.gov registry received information related to the study (NCT07130942) titled 'Molecular Hydrogen Inhalation: Effects on Health, Exercise Capacity and Inflammatory Respon... Read More
U.S., Aug. 20 -- ClinicalTrials.gov registry received information related to the study (NCT07130916) titled 'A Study of Aumolertinib in European Participants With Non-Small Cell Lung Cancer' on July 3... Read More
U.S., Aug. 20 -- ClinicalTrials.gov registry received information related to the study (NCT07129499) titled 'Shenbai Granules for Preventing Malignant Transformation of High-risk Colorectal Adenomas' ... Read More
U.S., Aug. 20 -- ClinicalTrials.gov registry received information related to the study (NCT07129642) titled 'Allogeneic Anti-CD19 CAR-T for Refractory Graves' Disease' on Aug. 06. Brief Summary: Grav... Read More
U.S., Aug. 20 -- ClinicalTrials.gov registry received information related to the study (NCT07130032) titled 'Efficacy And Safety Of Anti-PD-1/PD-L1 Antibodies In Combination With Bevacizumab And Metro... Read More